已收盤 09-20 16:00:00 美东时间
-0.020
-1.64%
New pseudovirus in vitro neutralization data show continued neutralizing activity of PEMGARDA™ (pemivibart) against KP.3.1.1, LB.1, and other SARS-CoV-2 variants tested Center for Disease Control reports
09-03 19:29
Patients treated with Invivyd's (NASDAQ:IVVD) Pemgarda (pemibivart) showed an 84% relative risk reduction in symptomatic COVID-19 compared to placebo in a phase 3 trial. In a group of all-comer immuno...
08-28 00:59
Invivyd, Inc. (NASDAQ:IVVD), a biopharmaceutical company devoted to delivering protection from serious viral infectious diseases, today announced that as part of the annual reconstitution of the Russell stock
07-01 19:11
Invivyd, Inc. (NASDAQ:IVVD) is possibly approaching a major achievement in its ...
05-29 22:13
HC Wainwright & Co.:重申Invivyd(IVVD.US)评级,由买入调整至买入评级, 目标价15.00美元。
05-25 00:50
Invivyd (IVVD) just unveiled an announcement. Invivyd, Inc. has announced the d...
04-12 19:52
Invivyd (NASDAQ:IVVD) said that the company’s board has appointed Jeremy Gowler as interim CEO, effective immediately. Gowler succeeds CEO Dave Hering. The company said a search for a permanent CEO is...
04-12 19:38
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts jus...
04-09 00:10
Invivyd (NASDAQ:IVVD) announced that PEMGARDA is now available for purchase in the U.S. for pre-exposure prophylaxis of COVID-19 in certain adults and adolescents with moderate-to-severe immune compro...
04-05 04:16
12月31日,Invivyd, Inc.(IVVD.US)公布财报,公告显示公司2023财年净利润为-1.99亿美元,同比增加17.43%;其中营业收入为0....
03-29 14:14